These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3081544

  • 21. Sensitivities of clinically significant organisms to four cephalosporins, ampicillin and mecillinam.
    Rahman M.
    Curr Med Res Opin; 1980; 7(2):96-100. PubMed ID: 6254727
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Studies with cefuroxime and cefoxitin.
    Geddes AM, McGhie D, Ball AP, Gould I.
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [Abstract] [Full Text] [Related]

  • 26. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [Abstract] [Full Text] [Related]

  • 27. Comparison of cefoxitin sodium and cefazolin.
    Gurwith M, Albritton W, Lank B, Harding G, Ronald A.
    J Antimicrob Chemother; 1978 Jul; 4(B):211-3. PubMed ID: 357389
    [No Abstract] [Full Text] [Related]

  • 28. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin.
    Gentry LO, Zeluff BJ, Cooley DA.
    Ann Thorac Surg; 1988 Aug; 46(2):167-71. PubMed ID: 3401076
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of cefonicid sodium versus cefoxitin sodium for the prevention of postoperative infections after nonelective cesarean section.
    Briggs GG, Moore BR, Bahado-Singh R, Lange S, Bogh P, Garite TJ.
    Clin Pharm; 1987 Sep; 6(9):718-21. PubMed ID: 3119278
    [No Abstract] [Full Text] [Related]

  • 30. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
    White JS, Gee C, Ledger WJ.
    J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F, Eandi M, Capra E, Soranzo ML, Bosio G, Bramato C, Salassa B, Andrini L, Robecchi GA.
    Minerva Med; 1980 May 26; 71(21):1515-24. PubMed ID: 7383410
    [Abstract] [Full Text] [Related]

  • 33. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
    Wallace RJ, Martin RR, Quinones FJ, Greenberg SB.
    Antimicrob Agents Chemother; 1981 Nov 26; 20(5):648-52. PubMed ID: 7034641
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The treatment of serious anaerobic infections.
    Greenberg RN, Scalcini MC, Sanders CV, Lewis AC.
    Scand J Infect Dis Suppl; 1980 Nov 26; suppl 25():84-8. PubMed ID: 7010541
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cefonicid vs. cefoxitin for cesarean section prophylaxis.
    Hartert RA, Benrubi G, Thompson RJ, Nuss RC.
    J Reprod Med; 1987 Dec 26; 32(12):907-10. PubMed ID: 3430499
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An overview: evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue.
    Kaye D.
    Rev Infect Dis; 1984 Dec 26; 6 Suppl 4():S835-8. PubMed ID: 6522926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.